A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

Engert, A

A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. [electronic resource] - Blood Jan 1997 - 403-10 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

0006-4971


Adult
Antibodies, Monoclonal--administration & dosage
Female
Hodgkin Disease--drug therapy
Humans
Immunotoxins--administration & dosage
Male
Receptors, Interleukin-2--immunology
Ricin--administration & dosage
Treatment Outcome